ATE444310T1 - Antiidiotypische antikörper die hiv-1 neutralisierende antikörper induzieren - Google Patents

Antiidiotypische antikörper die hiv-1 neutralisierende antikörper induzieren

Info

Publication number
ATE444310T1
ATE444310T1 AT03709690T AT03709690T ATE444310T1 AT E444310 T1 ATE444310 T1 AT E444310T1 AT 03709690 T AT03709690 T AT 03709690T AT 03709690 T AT03709690 T AT 03709690T AT E444310 T1 ATE444310 T1 AT E444310T1
Authority
AT
Austria
Prior art keywords
antibodies
relates
fragments
neutralizing
hiv
Prior art date
Application number
AT03709690T
Other languages
English (en)
Inventor
Renate Kunert
Robert Weik
Gabriela Stiegler
Hermann Katinger
Original Assignee
Polymun Scient Immunbio Forsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymun Scient Immunbio Forsch filed Critical Polymun Scient Immunbio Forsch
Application granted granted Critical
Publication of ATE444310T1 publication Critical patent/ATE444310T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4216—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
    • C07K16/4225—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03709690T 2002-01-17 2003-01-17 Antiidiotypische antikörper die hiv-1 neutralisierende antikörper induzieren ATE444310T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02001250 2002-01-17
PCT/EP2003/000455 WO2003059953A2 (en) 2002-01-17 2003-01-17 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies

Publications (1)

Publication Number Publication Date
ATE444310T1 true ATE444310T1 (de) 2009-10-15

Family

ID=8185289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709690T ATE444310T1 (de) 2002-01-17 2003-01-17 Antiidiotypische antikörper die hiv-1 neutralisierende antikörper induzieren

Country Status (8)

Country Link
US (1) US7625566B2 (de)
EP (1) EP1465928B1 (de)
JP (1) JP4495969B2 (de)
AT (1) ATE444310T1 (de)
AU (1) AU2003214044B8 (de)
CA (1) CA2473163C (de)
DE (1) DE60329461D1 (de)
WO (1) WO2003059953A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006110831A2 (en) * 2005-04-12 2006-10-19 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
ITTO20070066A1 (it) * 2007-01-30 2008-07-31 Pomona Biotechnologies Llc Anticorpi monoclonali anti-idiotipo mimotopi dell'antigene gp 120 di hiv
WO2008127651A1 (en) * 2007-04-13 2008-10-23 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
ITTO20080398A1 (it) * 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
ITTO20080964A1 (it) 2008-12-22 2010-06-23 Natimab Therapeutics S R L Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv
IT1395961B1 (it) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
EP2882455A4 (de) * 2012-08-08 2016-03-23 Network Immunology Inc Verfahren zur induktion einer immunantwort
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
US20190284259A1 (en) * 2016-07-22 2019-09-19 Georgia State University Research Foundation Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides
JP7595249B2 (ja) 2019-09-30 2024-12-06 国立大学法人 熊本大学 抗ＨＩＶ－１ Ｖ３抗体１Ｃ１０（０．５γ）に結合する抗体及びその抗原結合断片並びにその応用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1025692A (en) 1991-02-06 1992-08-13 Ciba-Geigy Ag Novel chimeric antiidiotypic monoclonal antibodies
EP0503916A1 (de) * 1991-03-11 1992-09-16 Idec Pharmaceuticals Corporation Verfahren zur Auswahl Antikörperreagenzes; Anti-Idiotype-Antikörper; und Aidsimpfstoffabfassungen
DE570357T1 (de) 1992-05-14 1994-07-28 Polimun Scientific Immunbiologische Forschungsgesellschaft Mbh, Wien Peptide, die Antikörper induzieren, die genetisch divergierende HIV-1 Isolationen neutralisieren.
AU5361794A (en) 1992-10-14 1994-05-09 Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
ES2214551T3 (es) 1995-11-02 2004-09-16 Schering Corporation Terapia de infusion continua de citocinas a baja dosis.
WO1997034636A1 (en) 1996-03-20 1997-09-25 Immunomedics, Inc. Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
CA2745736C (en) 1996-10-23 2016-11-22 The Trustees Of The University Of Pennsylvania Immunotherapy and improved vaccines

Also Published As

Publication number Publication date
EP1465928A2 (de) 2004-10-13
WO2003059953B1 (en) 2004-02-26
WO2003059953A2 (en) 2003-07-24
US7625566B2 (en) 2009-12-01
AU2003214044A1 (en) 2003-07-30
CA2473163C (en) 2011-12-06
DE60329461D1 (de) 2009-11-12
AU2003214044B2 (en) 2008-06-26
CA2473163A1 (en) 2003-07-24
JP2005517685A (ja) 2005-06-16
EP1465928B1 (de) 2009-09-30
US20050080240A1 (en) 2005-04-14
JP4495969B2 (ja) 2010-07-07
WO2003059953A3 (en) 2003-12-18
AU2003214044B8 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
MX2021004779A (es) Anticuerpos cd47 novedosos y metodos para usarlos.
ZA202308021B (en) Anti-ctla4 antibodies and methods of making and using the same
MA33402B1 (fr) Compositions et procédés de ciblage de la proteine c3b de complément par des anticorps
MX2025001919A (es) Anticuerpos anti-factor tisular, conjugados anticuerpo-farmaco y metodos relacionados
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
JOP20190248A1 (ar) بروتينات ربط مولد ضد trem2 واستخداماته
GEP20084484B (en) Antibodies to insulin-like growth factor i receptor
MY203138A (en) Anti-il2 receptor gamma antigen-binding proteins
MA31225B1 (fr) Anticorps neutralisants des cytomegalovirus humains et leur utilisation
NO982062L (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
MX2021015974A (es) Conjugados de anticuerpos y farmacos anti-factor tisular y metodos relacionados.
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
NO20081124L (no) Anti-CD 3 antistoff-formuleringer
MX2023014389A (es) Anticuerpos anti-sirp-alfa.
PH12021552334A1 (en) Antibodies to pyroglutamate amyloid-㟠and uses thereof
TR200401638T2 (tr) Bir reseptöre bağlanan peptidler ve bileşikler.
NO20060843L (no) RG1-antistoffer og anvendelser derav
DE60329461D1 (de) Antiidiotypische antikörper die hiv-1 neutralisierende antikörper induzieren
ZA202302392B (en) Antibodies against ilt2 and use thereof
MY170404A (en) Antigen binding proteins
MX2024015502A (es) Anticuerpos variantes que se unen a los receptores de linfocitos t gamma-delta
MX2025001452A (es) Anticuerpos anti-ccr8 y metodos de uso
DK1021534T3 (da) Hepatitis C-receptorprotein CD81
TR200103638T2 (tr) IL-8 Reseptör antagonistleri
GB0324656D0 (en) A protein involved in ovarian cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1465928

Country of ref document: EP